AVCRF (Avricore Health) Net Margin %: -465.63% (As of Mar. 2026)


What is Avricore Health Net Margin %?

Avricore Health AVCRF -3.93% Net Margin % is -465.63% as of Mar. 2026. The stock has 6 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Avricore Health ranks worse than 94.12% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Avricore Health's Net Income for the three months ended in Mar. 2026 was $-0.15 Mil. Avricore Health's Revenue for the three months ended in Mar. 2026 was $0.03 Mil. Therefore, Avricore Health's net margin for the quarter that ended in Mar. 2026 was -465.63%.

The historical rank and industry rank for Avricore Health's Net Margin % or its related term are showing as below:

AVCRF' s Net Margin % Range Over the Past 10 Years
Min: -27580   Med: -348.13   Max: -13.98
Current: -1379.17

AVCRF's Net Margin % is ranked worse than
94.12% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.405 vs AVCRF: -1379.17

Avricore Health  (OTCPK:AVCRF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Avricore Health Net Margin % Related Terms

Avricore Health Net Margin % Historical Data

* Premium members only.

The historical data trend for Avricore Health's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avricore Health Net Margin % Chart

Avricore Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,389.58 -46.27 -20.13 -13.99 -348.32

Avricore Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.88 -1,600.00 -1,014.81 -2,850.00 -465.63

AVCRF vs TMO, DHR, IDXX: Net Margin % Comparison

For the Diagnostics & Research subindustry, Avricore Health's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avricore Health Net Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's Net Margin % distribution charts can be found below:

* The bar in red indicates where Avricore Health's Net Margin % falls into.


Avricore Health Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Avricore Health's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.348/0.387
=-348.32 %

Avricore Health's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.149/0.032
=-465.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -465.63% mean?
Avricore Health (AVCRF) has a Net Margin % of -465.63% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Avricore Health and its competitors. According to the industry distribution chart, Avricore Health ranks #192 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 94.1%.
Is Avricore Health's Net Margin % too high?
Avricore Health's current Net Margin % is -465.63%. Based on the distribution chart, Avricore Health ranks #192 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Avricore Health's Net Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Avricore Health ranks #192 out of 204 companies for Net Margin %. This places Avricore Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Avricore Health and its competitors. Avricore Health's current Net Margin % is -465.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avricore Health stock overvalued right now?
Based on GuruFocus' analysis, Avricore Health (AVCRF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.02, compared to a current price of $0.03 — trading 50.9% above its estimated fair value. The current Net Margin % is -465.63%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Avricore Health (AVCRF), the current Net Margin % is -465.63% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avricore Health Business Description

Other Exchanges AVCR:Canada
Address 1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The company has only one segment, being the HealthTab - Point of Care Business in Canada. The company's revenues are generated from operating leases of the POCT system and the sale of testing panels. Geographically, the company operates in Canada and United Kingdom, it derives maximum revenue Canada.